MorphoSys AG | MOR Annual Report & Investor Relations Data
ISIN
DE0006632003
Ticker
MOR
Sector
Industry
Country
Germany
Year Founded
1992
ISIN
DE0006632003
Ticker
MOR
Sector
Industry
Country
Germany
Year Founded
1992
MorphoSys is a commercial-stage biopharmaceutical company dedicated to the discovery, development, and delivery of innovative cancer medicines.
Our ambition is to redefine how cancer is treated. As a commercial-stage biopharmaceutical company, we are driven by the urgency to deliver groundbreaking medicines, aspiring to give more life for people with cancer.
732
Worldwide
| Type | Document | Details | Language | Filing Date | File Number |
|---|
Access comprehensive European stock market filings data through a single, powerful API.
1,5M+
filings covered
18
European countries
30min
max latency
1 API
for all filings
Limited spots available. Join now!
| Date | Trading entity / Person | Association | Trade type | Volume |
|---|---|---|---|---|
| 20.09.2023 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 775.25 |
| 07.06.2023 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 52,800.00 |
| 06.06.2023 | Cluzel, Dr. Marc | Supervisory board | Buy | EUR 24,280.00 |
| 30.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 13,800.00 |
| 30.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 7,479.00 |
| 30.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 4,186.00 |
| 30.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 2,698.00 |
| 29.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 8,100.00 |
| 29.11.2022 | Reissner, Thomas | Supervisory board | Buy | EUR 5,000.00 |
| 28.11.2022 | Vermeylen, Krisja | Supervisory board | Buy | EUR 14,860.00 |
We currently don't have information about the management or supervisory board for this company. This information will be updated as soon as it becomes available.
DE0006632003
529900493806K77LRE72
SDAX
TecDAX
ABVX
Sector
Health Care
Country
France
ISIN
FR0012333284
Founded
Abivax develops innovative treatments modulating the body’s natural immune system machinery to treat patients with chronic inflammatory diseases, viral infections …
ADXN
Sector
Health Care
Country
Switzerland
ISIN
CH0029850754
Founded
2002
Addex Therapeutics is a clinical-stage pharmaceutical company focused on the development and commercialization of an emerging class of novel orally …
AEGIR
Sector
Health Care
Country
Sweden
ISIN
SE0014401121
Founded
2019
AegirBio is a Swedish diagnostics company that was founded to offer tests to monitor and optimize the dosage of biological …
None
Sector
Health Care
Country
North Macedonia
ISIN
MKALKA101011
Founded
1936
Alkaloid AD Skopje is a company which more than eight and a half decades, has been operating in the field …
ATB
Sector
Health Care
Country
Romania
ISIN
ROATBIACNOR9
Founded
1955
The leading manufacturer of generic drugs in Romania, Antibiotice SA was founded in December 1955. The company was listed on …
AZN
Sector
Health Care
Country
United Kingdom
ISIN
GB0009895292
Founded
1999
We are a global, science-led, patient-focused pharmaceutical company. We are tireless in seeking to realise the potential of what science …